(S)-colchicine increases expression ISO RGD:1359383 6480464 Colchicine results in increased expression of RASSF1 mRNA CTD PMID:20624997 1,2-dimethylhydrazine multiple interactions EXP 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of RASSF1 mRNA CTD PMID:22206623 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of RASSF1 mRNA CTD PMID:17555576 17alpha-ethynylestradiol multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RASSF1 mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of RASSF1 mRNA CTD PMID:17942748 17beta-estradiol affects expression EXP 6480464 Estradiol affects the expression of RASSF1 mRNA CTD PMID:15598610 17beta-estradiol increases methylation ISO RGD:1359383 6480464 Estradiol results in increased methylation of RASSF1 exon, Estradiol results in increased methylation of RASSF1 promoter CTD PMID:20008439 17beta-estradiol decreases expression ISO RGD:1359383 6480464 Estradiol results in decreased expression of RASSF1 mRNA CTD PMID:20008439 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RASSF1 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of RASSF1 mRNA CTD PMID:26290441 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of RASSF1 mRNA CTD PMID:21570461 more ... 2,4-diaminotoluene increases expression EXP 6480464 2, 4-diaminotoluene results in increased expression of RASSF1 mRNA CTD PMID:20713471 2,4-dinitrotoluene affects expression ISO RGD:1359383 6480464 2, 4-dinitrotoluene affects the expression of RASSF1 mRNA CTD PMID:21346803 2-acetamidofluorene increases methylation ISO RGD:1359383 6480464 2-Acetylaminofluorene results in increased methylation of RASSF1 promoter CTD PMID:20188851 2-methylcholine affects expression ISO RGD:1343966 6480464 beta-methylcholine affects the expression of RASSF1 mRNA CTD PMID:21179406 3-chloropropane-1,2-diol affects expression ISO RGD:1359383 6480464 alpha-Chlorohydrin affects the expression of RASSF1 mRNA CTD PMID:27884059 3-chloropropane-1,2-diol affects methylation ISO RGD:1359383 6480464 alpha-Chlorohydrin affects the methylation of RASSF1 promoter CTD PMID:27884059 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1343966 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RASSF1 mRNA CTD PMID:28628672 3-methylcholanthrene multiple interactions ISO RGD:1359383 6480464 [Diethylnitrosamine co-treated with Methylcholanthrene] results in decreased expression of RASSF1 protein, [Diethylnitrosamine co-treated with Methylcholanthrene] results in increased methylation of RASSF1 promoter CTD PMID:20970405 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of RASSF1 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine increases expression ISO RGD:1343966 6480464 Decitabine results in increased expression of RASSF1 mRNA, Decitabine results in increased expression of RASSF1 protein CTD PMID:16613325 more ... 5-aza-2'-deoxycytidine affects expression ISO RGD:1343966 6480464 Decitabine affects the expression of RASSF1 mRNA CTD PMID:18320071 5-aza-2'-deoxycytidine multiple interactions ISO RGD:1343966 6480464 [[Decitabine co-treated with trichostatin A] affects the methylation of RASSF1 promoter] which affects the expression of RASSF1 mRNA more ... CTD PMID:16613325 more ... 5-aza-2'-deoxycytidine affects methylation ISO RGD:1343966 6480464 Decitabine affects the methylation of RASSF1 promoter CTD PMID:17526942 more ... 5-aza-2'-deoxycytidine decreases methylation ISO RGD:1343966 6480464 Decitabine results in decreased methylation of RASSF1 gene, Decitabine results in decreased methylation of RASSF1 promoter CTD PMID:16613325 more ... acetamide increases expression ISO RGD:1359383 6480464 acetamide results in increased expression of RASSF1 mRNA CTD PMID:31881176 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of RASSF1 mRNA CTD PMID:19770486 aflatoxin B1 increases methylation ISO RGD:1343966 6480464 Aflatoxin B1 results in increased methylation of RASSF1 gene CTD PMID:27153756 aflatoxin B1 increases expression ISO RGD:1343966 6480464 Aflatoxin B1 results in increased expression of RASSF1 mRNA CTD PMID:22100608 amphetamine increases expression ISO RGD:1359383 6480464 Amphetamine results in increased expression of RASSF1 mRNA CTD PMID:30779732 antirheumatic drug increases expression ISO RGD:1343966 6480464 Antirheumatic Agents results in increased expression of RASSF1 mRNA CTD PMID:24449571 arsane increases methylation ISO RGD:1343966 6480464 Arsenic results in increased methylation of RASSF1 promoter CTD PMID:15987713 arsane affects methylation ISO RGD:1343966 6480464 Arsenic affects the methylation of RASSF1 gene CTD PMID:25304211 arsenic atom increases methylation ISO RGD:1343966 6480464 Arsenic results in increased methylation of RASSF1 promoter CTD PMID:15987713 arsenic atom affects methylation ISO RGD:1343966 6480464 Arsenic affects the methylation of RASSF1 gene CTD PMID:25304211 arsenous acid increases expression ISO RGD:1343966 6480464 Arsenic Trioxide results in increased expression of RASSF1 mRNA, Arsenic Trioxide results in increased expression of RASSF1 protein CTD PMID:16613325 , PMID:20079060 arsenous acid multiple interactions ISO RGD:1343966 6480464 [Arsenic Trioxide results in decreased methylation of RASSF1 promoter] which results in increased expression of RASSF1 mRNA more ... CTD PMID:16613325 arsenous acid decreases methylation ISO RGD:1343966 6480464 Arsenic Trioxide results in decreased methylation of RASSF1 gene, Arsenic Trioxide results in decreased methylation of RASSF1 promoter CTD PMID:16613325 , PMID:20079060 asbestos increases methylation ISO RGD:1343966 6480464 Asbestos results in increased methylation of RASSF1 promoter CTD PMID:15911247 atrazine increases expression ISO RGD:1343966 6480464 Atrazine results in increased expression of RASSF1 mRNA CTD PMID:22378314 benzo[a]pyrene increases expression EXP 6480464 Benzoapyrene results in increased expression of RASSF1 mRNA CTD PMID:22228805 benzo[a]pyrene increases methylation ISO RGD:1343966 6480464 Benzoapyrene results in increased methylation of RASSF1 promoter CTD PMID:27901495 benzophenanthridine decreases expression ISO RGD:1343966 6480464 Benzophenanthridines analog results in decreased expression of RASSF1 mRNA CTD PMID:23117580 bexarotene decreases expression EXP 6480464 bexarotene results in decreased expression of RASSF1 mRNA CTD PMID:17849452 bisphenol A affects expression ISO RGD:1359383 6480464 bisphenol A affects the expression of RASSF1 mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:1343966 6480464 bisphenol A results in decreased expression of RASSF1 mRNA CTD PMID:29275510 bisphenol A multiple interactions ISO RGD:1343966 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RASSF1 mRNA CTD PMID:28628672 cadmium atom increases methylation ISO RGD:1343966 6480464 Cadmium results in increased methylation of RASSF1 promoter CTD PMID:17938735 cadmium dichloride multiple interactions ISO RGD:1343966 6480464 decitabine inhibits the reaction [Cadmium Chloride results in decreased expression of RASSF1 protein], decitabine inhibits the reaction [Cadmium Chloride results in increased methylation of RASSF1 promoter] CTD PMID:17938735 cadmium dichloride decreases expression ISO RGD:1343966 6480464 Cadmium Chloride results in decreased expression of RASSF1 protein CTD PMID:17938735 carbon nanotube increases expression EXP 6480464 Nanotubes more ... CTD PMID:25554681 chrysene increases expression EXP 6480464 chrysene results in increased expression of RASSF1 mRNA CTD PMID:26377693 cisplatin multiple interactions ISO RGD:1343966 6480464 [Cisplatin co-treated with panobinostat] affects the expression of RASSF1 mRNA more ... CTD PMID:21791302 more ... cisplatin increases expression ISO RGD:1343966 6480464 Cisplatin results in increased expression of RASSF1 mRNA CTD PMID:27594783 cisplatin increases response to substance ISO RGD:1343966 6480464 RASSF1 protein results in increased susceptibility to Cisplatin, RASSF1 results in increased susceptibility to Cisplatin CTD PMID:17444856 , PMID:21880625 crocidolite asbestos increases expression ISO RGD:1343966 6480464 Asbestos, Crocidolite results in increased expression of RASSF1 mRNA CTD PMID:18687144 crocidolite asbestos affects expression ISO RGD:1343966 6480464 Asbestos, Crocidolite affects the expression of RASSF1 mRNA CTD PMID:17331233 cyclosporin A increases expression ISO RGD:1343966 6480464 Cyclosporine results in increased expression of RASSF1 mRNA CTD PMID:20106945 , PMID:25562108 dexamethasone multiple interactions ISO RGD:1343966 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RASSF1 mRNA CTD PMID:28628672 dextran sulfate multiple interactions EXP 6480464 [RASSF1 gene mutant form results in increased susceptibility to Dextran Sulfate] which results in decreased activity of STK4 protein more ... CTD PMID:24146755 dextran sulfate increases response to substance EXP 6480464 RASSF1 gene mutant form results in increased susceptibility to Dextran Sulfate CTD PMID:24146755 diarsenic trioxide decreases methylation ISO RGD:1343966 6480464 Arsenic Trioxide results in decreased methylation of RASSF1 gene, Arsenic Trioxide results in decreased methylation of RASSF1 promoter CTD PMID:16613325 , PMID:20079060 diarsenic trioxide multiple interactions ISO RGD:1343966 6480464 [Arsenic Trioxide results in decreased methylation of RASSF1 promoter] which results in increased expression of RASSF1 mRNA more ... CTD PMID:16613325 diarsenic trioxide increases expression ISO RGD:1343966 6480464 Arsenic Trioxide results in increased expression of RASSF1 mRNA, Arsenic Trioxide results in increased expression of RASSF1 protein CTD PMID:16613325 , PMID:20079060 diazinon increases methylation ISO RGD:1343966 6480464 Diazinon results in increased methylation of RASSF1 gene CTD PMID:22964155 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of RASSF1 mRNA CTD PMID:17361019 , PMID:21266533 dioxygen multiple interactions EXP 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RASSF1 mRNA CTD PMID:30529165 doxorubicin decreases expression ISO RGD:1343966 6480464 Doxorubicin results in decreased expression of RASSF1 mRNA CTD PMID:29803840 elemental selenium increases expression ISO RGD:1343966 6480464 Selenium results in increased expression of RASSF1 mRNA CTD PMID:19244175 ethanol multiple interactions EXP 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of RASSF1 mRNA CTD PMID:30517762 ethyl methanesulfonate increases expression ISO RGD:1343966 6480464 Ethyl Methanesulfonate results in increased expression of RASSF1 mRNA CTD PMID:23649840 etoposide multiple interactions ISO RGD:1343966 6480464 [RASSF1 co-treated with Etoposide] affects the folding of and results in increased activity of BAX protein more ... CTD PMID:21880625 etoposide increases response to substance ISO RGD:1343966 6480464 RASSF1 results in increased susceptibility to Etoposide CTD PMID:21880625 fluoranthene multiple interactions EXP 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of RASSF1 mRNA CTD PMID:28329830 folic acid multiple interactions EXP 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of RASSF1 mRNA CTD PMID:22206623 folic acid increases expression ISO RGD:1343966 6480464 Folic Acid deficiency results in increased expression of RASSF1 mRNA, Folic Acid results in increased expression of RASSF1 mRNA CTD PMID:28752528 folic acid increases methylation ISO RGD:1343966 6480464 Folic Acid deficiency results in increased methylation of RASSF1 promoter CTD PMID:28752528 furan decreases expression ISO RGD:1359383 6480464 furan results in decreased expression of RASSF1 mRNA CTD PMID:24614236 furan increases expression EXP 6480464 furan results in increased expression of RASSF1 mRNA CTD PMID:24183702 furan increases methylation ISO RGD:1359383 6480464 furan results in increased methylation of RASSF1 promoter CTD PMID:24614236 gentamycin increases expression ISO RGD:1359383 6480464 Gentamicins results in increased expression of RASSF1 mRNA CTD PMID:22061828 glycidol affects methylation ISO RGD:1359383 6480464 glycidol affects the methylation of RASSF1 promoter CTD PMID:27884059 glycidol affects expression ISO RGD:1359383 6480464 glycidol affects the expression of RASSF1 mRNA CTD PMID:27884059 hydrogen chloride decreases expression ISO RGD:1343966 6480464 Hydrochloric Acid results in decreased expression of RASSF1 mRNA CTD PMID:15046208 indole-3-methanol affects expression ISO RGD:1359383 6480464 indole-3-carbinol affects the expression of RASSF1 mRNA CTD PMID:21396975 indometacin multiple interactions ISO RGD:1343966 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RASSF1 mRNA CTD PMID:28628672 isoprenaline decreases expression ISO RGD:1359383 6480464 Isoproterenol results in decreased expression of RASSF1 mRNA, Isoproterenol results in decreased expression of RASSF1 protein CTD PMID:24945829 menadione affects expression ISO RGD:1343966 6480464 Vitamin K 3 affects the expression of RASSF1 mRNA CTD PMID:20044591 methapyrilene increases expression ISO RGD:1359383 6480464 Methapyrilene results in increased expression of RASSF1 mRNA CTD PMID:30467583 methyl methanesulfonate increases expression ISO RGD:1343966 6480464 Methyl Methanesulfonate results in increased expression of RASSF1 mRNA CTD PMID:23649840 methylmercury chloride increases expression ISO RGD:1343966 6480464 methylmercuric chloride results in increased expression of RASSF1 mRNA CTD PMID:28001369 mitomycin C increases response to substance ISO RGD:1343966 6480464 RASSF1 protein results in increased susceptibility to Mitomycin CTD PMID:17444856 N-nitrosodiethylamine multiple interactions ISO RGD:1359383 6480464 [Diethylnitrosamine co-treated with Methylcholanthrene] results in decreased expression of RASSF1 protein, [Diethylnitrosamine co-treated with Methylcholanthrene] results in increased methylation of RASSF1 promoter CTD PMID:20970405 nickel atom increases expression EXP 6480464 Nickel analog results in increased expression of RASSF1 mRNA, Nickel analog results in increased expression of RASSF1 protein CTD PMID:24579805 nickel subsulfide decreases expression ISO RGD:1359383 6480464 nickel subsulfide results in decreased expression of RASSF1 mRNA CTD PMID:21565688 nickel subsulfide increases methylation ISO RGD:1359383 6480464 nickel subsulfide results in increased methylation of RASSF1 gene CTD PMID:21565688 orphenadrine affects expression ISO RGD:1359383 6480464 Orphenadrine affects the expression of RASSF1 mRNA CTD PMID:23665939 panobinostat multiple interactions ISO RGD:1343966 6480464 [Cisplatin co-treated with panobinostat] affects the expression of RASSF1 mRNA CTD PMID:21791302 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of RASSF1 mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:1343966 6480464 Acetaminophen results in increased expression of RASSF1 mRNA CTD PMID:22230336 , PMID:29067470 phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of RASSF1 mRNA CTD PMID:23091169 phenylephrine decreases response to substance EXP 6480464 RASSF1 protein results in decreased susceptibility to Phenylephrine CTD PMID:19652091 phenylephrine decreases response to substance ISO RGD:1359383 6480464 RASSF1 protein results in decreased susceptibility to Phenylephrine CTD PMID:19652091 procainamide increases expression ISO RGD:1343966 6480464 Procainamide results in increased expression of RASSF1 protein CTD PMID:17938735 propiconazole increases expression EXP 6480464 propiconazole results in increased expression of RASSF1 mRNA CTD PMID:21278054 quercetin increases expression ISO RGD:1343966 6480464 Quercetin results in increased expression of RASSF1 mRNA CTD PMID:21632981 selenium atom increases expression ISO RGD:1343966 6480464 Selenium results in increased expression of RASSF1 mRNA CTD PMID:19244175 silicon dioxide increases expression ISO RGD:1343966 6480464 Silicon Dioxide results in increased expression of RASSF1 mRNA CTD PMID:25351596 sodium arsenite increases expression ISO RGD:1343966 6480464 sodium arsenite results in increased expression of RASSF1 mRNA CTD PMID:12634122 sodium arsenite affects methylation ISO RGD:1343966 6480464 sodium arsenite affects the methylation of RASSF1 gene CTD PMID:28589171 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of RASSF1 mRNA CTD PMID:31558096 Soman increases expression ISO RGD:1359383 6480464 Soman results in increased expression of RASSF1 mRNA CTD PMID:19281266 succimer multiple interactions EXP 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RASSF1 mRNA, [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of RASSF1 mRNA CTD PMID:21641980 , PMID:26378955 sunitinib decreases expression ISO RGD:1343966 6480464 Sunitinib results in decreased expression of RASSF1 mRNA CTD PMID:31533062 T-2 toxin increases expression ISO RGD:1359383 6480464 T-2 Toxin results in increased expression of RASSF1 mRNA CTD PMID:26141394 tamoxifen affects expression EXP 6480464 Tamoxifen affects the expression of RASSF1 mRNA CTD PMID:17555576 tetrachloromethane multiple interactions EXP 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of RASSF1 mRNA CTD PMID:30517762 thioacetamide increases expression ISO RGD:1359383 6480464 Thioacetamide results in increased expression of RASSF1 mRNA CTD PMID:23411599 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of RASSF1 mRNA CTD PMID:27760801 trichostatin A multiple interactions ISO RGD:1343966 6480464 [[decitabine co-treated with trichostatin A] affects the methylation of RASSF1 promoter] which affects the expression of RASSF1 mRNA, [decitabine co-treated with trichostatin A] affects the expression of RASSF1 protein CTD PMID:17019711 , PMID:18819746 urethane increases expression ISO RGD:1343966 6480464 Urethane results in increased expression of RASSF1 mRNA CTD PMID:28818685 valproic acid affects expression ISO RGD:1343966 6480464 Valproic Acid affects the expression of RASSF1 mRNA CTD PMID:25979313 vincaleukoblastine increases expression ISO RGD:1359383 6480464 Vinblastine results in increased expression of RASSF1 mRNA CTD PMID:20624997 vincristine increases expression ISO RGD:1359383 6480464 Vincristine results in increased expression of RASSF1 mRNA CTD PMID:20624997 vinyl carbamate decreases expression EXP 6480464 vinyl carbamate results in decreased expression of RASSF1 mRNA CTD PMID:17849452 vitamin E increases expression ISO RGD:1343966 6480464 Vitamin E results in increased expression of RASSF1 mRNA CTD PMID:19244175 zearalenone increases expression ISO RGD:1343966 6480464 Zearalenone results in increased expression of RASSF1 mRNA CTD PMID:28965971 zinc atom increases expression EXP 6480464 Zinc results in increased expression of RASSF1 mRNA CTD PMID:31505237 zinc(0) increases expression EXP 6480464 Zinc results in increased expression of RASSF1 mRNA CTD PMID:31505237
